Catalent Applied Drug Delivery Institute Partners with AAPS on 3rd Annual Global Academic Competition

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-02-05-2014
Volume 10
Issue 2

Competition seeks to encourage academic research and accelerate drug delivery applications.

Catalent Applied Drug Delivery Institute’s “3rd Annual Global Academic Competition for Life Science Leaders of Tomorrow,” in collaboration with the American Association of Pharmaceutical Scientists (AAPS) is now open for entries at www.drugdeliveryinstitute.com/global-academic-competition. The aim is to foster an interest in drug delivery among university students enrolled in pharmaceutical sciences, industrial pharmacy, drug delivery, drug development, or other related courses. Participating universities in the US include, St. John’s, Rutgers, New Jersey Institute of Technology, and University of North Carolina at Chapel Hill. In Europe, participating universities include Saarland and Düsseldorf, Germany and Bath and Bristol in the UK. /p>

Participants will compete for one of five prizes of $2,000, a complimentary, one-year AAPS membership, and the opportunity to have their submissions published by Catalent in the Institute and/or industry publications. Articles submitted should be original and based on topics such as drug development, improving therapeutic profiles and bioavailability, pre-formulation, drug delivery innovation in inhalation, biologics, lipid-based systems, crossing the blood-brain barrier, or on the delivery of drugs in certain patient groups such as pediatrics. The deadline for entries is March 28, 2014. More details on the competition, including entry forms and contest rules can be found here.

Source: Catalent Applied Drug Delivery Institute

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content